Macro Economic Analysis - The Chinese economy showed better-than-expected performance in Q1 2025, indicating a strong start to the year [1] - Policy measures are supporting commodity inflation, as reflected in the March price data [1] Trade Data Insights - The "export rush" is nearing its end, as indicated by the March import and export data [2] - The U.S. CPI inflation data for March reflects a brief period of calm in the overseas macroeconomic environment [2] Capital Market Overview - The bond market is experiencing a strong and volatile phase, suggesting opportunities for long-term bond fund investments [3] - U.S. tech stocks have faced significant setbacks, raising questions about the market's bottom [3] - Tariff pressures are causing dramatic fluctuations in both stock and bond markets [3] Industry Analysis - The pharmaceutical industry is accelerating its digital transformation, with AI technology playing a crucial role in this new journey [5] - Positive policy measures are contributing to stability in the A-share market [5] - Tariff expectations are being driven by policy responses, highlighting the need to monitor these developments [5] - Market volatility continues as the impact of tariffs temporarily eases [5] Weekly Outlook - Recent tariff measures have exceeded expectations, leading to a significant rise in risk-averse sentiment [6]
招商银行研究院微信报告汇总(2025年4月)
招商银行研究·2025-05-11 07:45